title: Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain.
abstract: Hepatocarcinogenesis sensitivity (Hcs1, 2) and resistance (Hcr1-3) loci have been identified by linkage analysis on rat chromosomes 7 and 1, and 10, 4, and 8, respectively. Cytogenetic studies documented deletions on chromosomes 3 and 6 of neoplastic rat hepatocytes. Hepatocellular carcinomas (HCCs) were produced in F1 hybrid rats between Long-Evans (LE) and Fisher 344 (F344) rats. Scanning of the above chromosomes for loss of heterozygosity (LOH) showed allelic imbalance (AI) at multiple regions on chromosomes 6, 7, and 10q. Detailed deletion mapping of chromosome 10 localized a putative suppressor Hcr1 gene to within a 3.2-cM interval flanked by D10Rat51 and D10Rat121. Two other distinct regions with frequent AIs were found inside the Hcr1 locus, at marker loci including DNaseI and Mrp genes, and in a segment including 4 consecutive markers (D10Rat64, D10Rat182, D10Rat113, D10Rat216). In 40% of HCCs, AI was seen at the p53 locus. AI on chromosome 7 occurred at the Hcs1 locus, where is located c-myc, which is amplified in HCCs, suggesting allelic gain. Most AIs occurred in poorly/moderately differentiated carcinomas, and a few events were seen in well-differentiated tumors on chromosomes 7 and 10. These data suggest that alteration of a cluster of oncosuppressor genes on 10q is important for HCC progression. The existence of AI on segments of rat chromosomes 6, 7, and 10, syntenic to chromosomal segments of human HCCs where chromosomal gains or deletions occur, suggests a commonality of some molecular events in the pathogenesis of HCCs in rats and humans. Our map provides information toward cloning putative oncosuppressor genes associated with this carcinoma.
authors.affiliation: Department of Biomedical Sciences, Division of Experimental Pathology and Oncology, University of Sassari. Italy.
authors.forename: M R
authors.initials: MR
authors.lastname: De Miglio
authors.forename: M R
authors.initials: MR
authors.lastname: Muroni
authors.forename: M M
authors.initials: MM
authors.lastname: Simile
authors.forename: P
authors.initials: P
authors.lastname: Virdis
authors.forename: G
authors.initials: G
authors.lastname: Asara
authors.forename: M
authors.initials: M
authors.lastname: Frau
authors.forename: D F
authors.initials: DF
authors.lastname: Calvisi
authors.forename: M A
authors.initials: MA
authors.lastname: Seddaiu
authors.forename: R M
authors.initials: RM
authors.lastname: Pascale
authors.forename: F
authors.initials: F
authors.lastname: Feo
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000235:genetics*; D002874:Chromosome Mapping; D002875:Chromosomes / Q000235:genetics*; D016147:Genes, Tumor Suppressor / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D008113:Liver Neoplasms / Q000235:genetics*; D019656:Loss of Heterozygosity; D051381:Rats; D011919:Rats, Inbred Strains; D014157:Transcription Factors / Q000235:genetics*
chemical_list: C092941:RASSF7 protein, human; D014157:Transcription Factors